Skip to main content
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.130
-0.100 (-3.10%)
Mar 9, 2026, 1:58 PM EDT - Market open

Prelude Therapeutics Revenue

Prelude Therapeutics had revenue of $6.50M in the quarter ending September 30, 2025, with 116.67% growth. This brings the company's revenue in the last twelve months to $10.50M, up 250.00% year-over-year. In the year 2024, Prelude Therapeutics had annual revenue of $7.00M.

Revenue (ttm)
$10.50M
Revenue Growth
+250.00%
P/S Ratio
24.76
Revenue / Employee
$80,153
Employees
131
Market Cap
257.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.00M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus Oncology 277.73M
Cellectis 82.55M
Fennec Pharmaceuticals 38.79M
OmniAb 18.67M
AC Immune 5.48M
Surrozen 3.60M
Abeona Therapeutics 400.00K
Inhibikase Therapeutics 1.00
Revenue Rankings

PRLD News

More News